In human HCC, pro-inflammatory M1-like CD68+HLA-DR+ TAMs are more abundant in the early stages of HCC progression and undergo a phenotypic switch towards immunosuppressive M2-like CD68+ HLA-DR− TAMs once the tumor is more established [71,361,374]. The gene discussed is CD68; the disease is neoplasm.